2 Results Found

Advanced Search

Select all

Results per page

Select all

Review

16 Citations

5,111 Views

15 Pages

Specific Therapy for T2 Asthma

Diego Bagnasco,
Elisa Testino,
Stefania Nicola,
Laura Melissari,
Maria Russo,
Rikki Frank Canevari,
Luisa Brussino and
Giovanni Passalacqua

J. Pers. Med.2022, 12(4), 593;https://doi.org/10.3390/jpm12040593

-

7 April 2022

Asthma is a disease with high incidence and prevalence, and its severe form accounts for approximately 10% of asthmatics. Over the last decade, the increasing knowledge of the mechanisms underlying the disease allowed the development of biological dr...

Full Article

Review

3 Citations

2,719 Views

17 Pages

Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy

Diego Bagnasco,
Edoardo Vincenzo Savarino,
Mona-Rita Yacoub,
Fulvio Braido,
Maria Giulia Candeliere,
Edoardo Giannini,
Giovanni Passalacqua and
Elisa Marabotto

Pharmaceutics2023, 15(9), 2359;https://doi.org/10.3390/pharmaceutics15092359

-

21 September 2023

The role of type 2 inflammation has been progressively associated with many diseases, including severe asthma, atopic dermatitis, nasal polyposis, eosinophilic granulomatosis with polyangiitis, and, recently, eosinophilic esophagitis. Despite this, t...

Full Article